Javascript must be enabled for this website to work.

#script { display:none; } #noScript{ width: 350px; height: 175px; text-align: center; background: white; padding: 35px; display: block; margin-top: -87px; top: 50%; position: absolute; border-bottom: 1px solid #c2c2c2; border-left: 1px solid #e6e6e6; border-right: 1px solid #e6e6e6; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; margin-left: 50%; left: -175px; } #noScript img{width:100%;} body{background:#f7f7f7;}

respiratory

Cystic fibrosis

Experts caution against using HbA1c as a screening tool in CF

By Jennie James

12 Nov 2015

Despite a large prospective study recently suggesting that HbA1c is effective as a screening tool for cystic fibrosis related diabetes (CFRD), a group of Australian experts have warned against its widespread use for now. In April this year a study published in the Journal of Cystic Fibrosis showed that at a cut off level of ...

Already a member?

Enter your email to keep reading.

Not a member yet?

Join now for free, independent news relevant to your specialty. the limbic is intended for practicing health care professionals only.

Title: *

Name: *

Email: *

AHPRA Number: *

Can't remember your AHPRA number? Search for it here

What's your primary area of interest? *

The limbic's weekly newsletter is a round up of key news highlights that's relevant to your specialty. The newsletter may contain advertising and educational or promotional material from carefully selected industry partners including pharmaceutical companies, government and not-for-profit organisations.

You will not receive advertisers only emails and your details will not be shared with any other party.

I would like to receive the limbic newsletter *

I have read and agree to the limbic Terms and Conditions & Privacy Policy *

Cancel